Company · CIK 0001723128 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Amneal Pharmaceuticals, Inc. · AMRX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 GForm 4 → | Sep 21, 4:33 pm EDT | J Kevin BuchiDirector | 20,445 | — | — | 75,077 | — | |
| Sep 11, 2026 MForm 4 → | Sep 14, 4:10 pm EDT | J Kevin BuchiDirector | 20,445 | $14.45 | $295,430 | 95,522 | — | |
| Sep 1, 2026 GForm 4 → | Sep 2, 5:03 pm EDT | Andrew S BoyerExecutive Vice President | 80,000 | — | — | 193,646 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 MForm 4 → | Sep 14, 4:10 pm EDT | J Kevin BuchiDirector | 20,445 | — | — | 0 | — |